C07D 209/74
With an oxygen atom in position 1
Official title: with an oxygen atom in position 1
C07D209/74 (With an oxygen atom in position 1) appears on 5 US grants and 3 published applications in this corpus.
Search patents in C07D- Granted patents
- 5
- Published applications
- 3
- Assignees
- 2
- Inventors
- 6
- Latest grant
- 11 Mar 2008
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function11 Mar 2008US 7,342,034 B2Bristol-Myers Squibb Company
- Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function6 Nov 2007US 7,291,637 B2Bristol-Myers Squibb Company
- Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function8 Aug 2006US 7,087,636 B2Bristol-Myers Squibb Company
- Substituted N-biphenylyl lactams21 Sep 1993US 5,246,940 AOrtho Pharmaceutical Corporation
- Substituted n-biphenylyl lactams26 Jan 1993US 5,182,288 AOrtho Pharmaceutical Corporation
- Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function26 Jan 2006US 2006/0020002 A1Bristol-Myers Squibb Company
- Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function25 Aug 2005US 2005/0187273 A1Bristol-Myers Squibb Company
- Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function25 Sep 2003US 2003/0181728 A1Bristol-Myers Squibb Company
Most cited
By later US patents